SCHEMBL21252178

SCHEMBL21252178

CCc1cc(OC)c(Cl)c(-c2cc3cnc(SC)nc3c(N3CCC(O)CC3)n2)c1C

nearest known ligand 0.35

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
▸ MEN1 O00255 1/20 0.35
▸ KMT2A Q03164 1/20 0.35
▸ TTK P33981 1/20 0.34
▸ PDE5A O76074 3/20 0.33
▸ SUV39H2 Q9H5I1 1/20 0.33
▸ NEK2 P51955 5/20 0.33
▸ PLK1 P53350 1/20 0.33
▸ NEK1 Q96PY6 1/20 0.33
▸ PDE4B Q07343 3/20 0.33
▸ PDE4A P27815 2/20 0.33
▸ PDE4C Q08493 2/20 0.33
▸ PDE4D Q08499 2/20 0.33
▸ PDE11A Q9HCR9 2/20 0.33
▸ PDE3B Q13370 1/20 0.33
▸ TP53 P04637 1/20 0.33
▸ MALT1 Q9UDY8 1/20 0.32
▸ PDCD1 Q15116 1/20 0.32
▸ CD274 Q9NZQ7 1/20 0.32
▸ F10 P00742 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29578676 0.89 SUV39H2 (0.36) TTKPDE5ASUV39H2NEK2PLK1
SCHEMBL21240427 0.89 SUV39H2 (0.36) TTKPDE5ASUV39H2NEK2PLK1
SCHEMBL20331101 0.81 MEN1 (0.36) MEN1KMT2ASUV39H2PDE4BPDE4A
SCHEMBL20331783 0.80 F10 (0.33) SUV39H2PDE4BPDE4APDE4CPDE4D
SCHEMBL21240243 0.80 TTK (0.38) TTKNEK2PLK1NEK1PDE4B
SCHEMBL29578389 0.80 TTK (0.38) TTKNEK2PLK1NEK1PDE4B
SCHEMBL24488213 0.79 GAK (0.33) MEN1KMT2ATTKNEK2PLK1
SCHEMBL21251736 0.79 TTK (0.35) TTKNEK2PDE3BTP53
SCHEMBL20331789 0.78 NOS1 (0.38) MEN1KMT2ATTKPDE4BPDE4A
SCHEMBL21240537 0.78 NOS1 (0.36) MEN1KMT2APDE4BPDE4APDE4C

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3524603-A1 FGFR4 INHIBITOR, PREPARATION METHOD THEREFOR AND PHARMACEUTICAL USE THEREOF Abbisko Therapeutics Co., Ltd. (CN) 2019-08-14 — — EP disclosed
Send feedback